Bharat Bio’s Telangana unit failed GMP test, led to Covaxin suspension: WHO, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech’s flagship vaccine manufacturing facility at Hyderabad’s Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement., It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech’s flagship vaccine manufacturing facility at Hyderabad’s Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement., , Read More